Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Untreated Pancreatic Ductal Adenocarcinoma”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Ended earlyNCT02732938
What this trial is testing

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 22
Early research (Phase 1)Study completedNCT03412799
What this trial is testing

Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Cancer Stage IVStage IV Pancreatic Cancer
Panbela Therapeutics, Inc. 50
Large-scale testing (Phase 3)Looking for participantsNCT05254171
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV
Panbela Therapeutics, Inc. 600
Testing effectiveness (Phase 2)Looking for participantsNCT06825546
What this trial is testing

Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT07522073
What this trial is testing

Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Solid Tumors
Incyte Corporation 588
Testing effectiveness (Phase 2)Study completedNCT01839487
What this trial is testing

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Halozyme Therapeutics 279
Large-scale testing (Phase 3)Ended earlyNCT02101021
What this trial is testing

Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Sierra Oncology LLC - a GSK company 25
Testing effectiveness (Phase 2)Looking for participantsNCT07259317
What this trial is testing

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
AdenocarcinomaCarcinoma, Pancreatic Ductal
Corcept Therapeutics 60
Testing effectiveness (Phase 2)Study completedNCT04054362
What this trial is testing

Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Barts & The London NHS Trust 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03915444
What this trial is testing

Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
HonorHealth Research Institute 42
Testing effectiveness (Phase 2)Ended earlyNCT02109445
What this trial is testing

Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies

Who this might be right for
Metastatic Cancer Pancreas
Pfizer 3
Not applicableWithdrawnNCT02414100
What this trial is testing

Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

Who this might be right for
Pancreatic Ductal AdenocarcinomaStage IA Pancreatic CancerStage IB Pancreatic Cancer+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Early research (Phase 1)Ended earlyNCT02468557
What this trial is testing

Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Previously Untreated Pancreatic Ductal AdenocarcinomaRelapsed/Refractory Pancreatic Ductal Adenocarcinoma
Gilead Sciences 16
Large-scale testing (Phase 3)Ended earlyNCT02715804
What this trial is testing

PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Carcinoma
Halozyme Therapeutics 492
Testing effectiveness (Phase 2)Study completedNCT01893801
What this trial is testing

Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA

Who this might be right for
Stage IV Pancreatic Cancer
Pancreatic Cancer Research Team 25
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03415854
What this trial is testing

Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma+2 more
HonorHealth Research Institute 11
Testing effectiveness (Phase 2)Study completedNCT02754726
What this trial is testing

Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
HonorHealth Research Institute 35
Testing effectiveness (Phase 2)WithdrawnNCT06398587
What this trial is testing

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more
OHSU Knight Cancer Institute